For body composition research, calculating your dose is identical, but the supporting protocol matters more
So, thanks for sharing your experience with us Elizabeth
anyone with copper-metabolism disorders (e.g., Wilsons disease) is exactly the population that should avoid copper-peptide exposure in any research context
As of this spring there is still no randomized trial of BPC-157 in humans for any condition
Worked example: 10 mg vial with 2 mL water Concentration: 10 mg divided by 2 mL = 5 mg/mL For a 2.5 mg dose: 2.5 divided by 5 = 0.50 mL = 50 units For a 5 mg dose: 5 divided by 5 = 1.0 mL = 100 units For a 7.5 mg dose: 7.5 divided by 5 = 1.5 mL = 150 units (requires a larger syringe or two draws) Worked example: 30 mg vial with 3 mL water Concentration: 30 mg divided by 3 mL = 10 mg/mL For a 2.5 mg dose: 2.5 divided by 10 = 0.25 mL = 25 units For a 5 mg dose: 5 divided by 10 = 0.50 mL = 50 units For a 10 mg dose: 10 divided by 10 = 1.0 mL = 100 units For a 15 mg dose: 15 divided by 10 = 1.5 mL = 150 units Notice how the 10 mg/mL concentration makes the math cleanest
In animal or ex vivo experimental models for mechanistic investigation of peptidemetal interactions, copper bioavailability, and metal-mediated tissue signalling processes